CLDN1 and breast carcinoma: Moreover, the investigation also revealed ADAM15 variant-specific and catalytic activity-dependent upregulation of the expression of the tight junction protein Claudin-1, which may help to explain some aspects of the actions of ADAM15 in breast cancer.